Gene · 799
Papers3,617
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
701 to 720 of 3,617
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Green Tea Catechins: Nature's Way of Preventing and Treating Cancer. | Int J Mol Sci | 2022 | 36142616 | PubTator, text mining | PubMed |
| Tumor-Promoting Activity and Proteomic Profiling of Cisplatin/Oxaliplatin-Derived DAMPs in Cholangiocarcinoma Cells. | Int J Mol Sci | 2022 | 36142453 | PubTator, text mining | PubMed |
| Pyroptosis and Its Role in the Modulation of Cancer Progression and Antitumor Immunity. | Int J Mol Sci | 2022 | 36142404 | PubTator, text mining | PubMed |
| Moderate and Severe Dental Fluorosis in the Rural Population of Anantapur, India: Change in Their Biological Susceptibility? | Int J Environ Res Public Health | 2022 | 36141562 | PubTator, text mining | PubMed |
| Experimental Study on the Inhibition of RANKL-Induced Osteoclast Differentiation In Vitro by Metformin Hydrochloride. | Int J Endocrinol | 2022 | 36132487 | PubTator, text mining | PubMed |
| Landscapes of synchronous multiple primary cancers detected by next-generation sequencing. | FEBS Open Bio | 2022 | 36128740 | PubTator, text mining | PubMed |
| Role of Calcitonin Gene-Related Peptide on the Gastrointestinal Symptoms of Migraine-Clinical Considerations: A Narrative Review. | Neurology | 2022 | 36127137 | PubTator, text mining | PubMed |
| Limbic Encephalitis following Allogeneic Hematopoietic Stem Cell Transplantation. | Case Reports Immunol | 2022 | 36124252 | PubTator, text mining | PubMed |
| A scalable system for the fast production of RNA with homogeneous terminal ends. | RNA Biol | 2022 | 36121187 | PubTator, text mining | PubMed |
| A non-canonical scaffold-type E3 ligase complex mediates protein UFMylation. | EMBO J | 2022 | 36121123 | PubTator, text mining | PubMed |
| Multimodal regulation of the osteoclastogenesis process by secreted group IIA phospholipase A2. | Front Cell Dev Biol | 2022 | 36105351 | PubTator, text mining | PubMed |
| A Randomized Phase 2 Study of 5-Aminolevulinic Acid Hydrochloride and Sodium Ferrous Citrate for the Prevention of Nephrotoxicity Induced by Cisplatin-Based Chemotherapy of Lung Cancer. | Oncology | 2022 | 36099876 | PubTator, text mining | PubMed |
| Identification of a binding site on soluble RANKL that can be targeted to inhibit soluble RANK-RANKL interactions and treat osteoporosis. | Nat Commun | 2022 | 36097003 | PubTator, text mining | PubMed |
| Naturally Acquired Kelch13 Mutations in Plasmodium falciparum Strains Modulate In Vitro Ring-Stage Artemisinin-Based Drug Tolerance and Parasite Survival in Response to Hyperoxia. | Microbiol Spectr | 2022 | 36094220 | PubTator, text mining | PubMed |
| How zoledronic acid improves osteoporosis by acting on osteoclasts. | Front Pharmacol | 2022 | 36091799 | PubTator, text mining | PubMed |
| Association of TRPV5, CASR, and CALCR genetic variants with kidney stone disease susceptibility in Egyptians through main effects and gene-gene interactions. | Urolithiasis | 2022 | 36088585 | PubTator, text mining | PubMed |
| Protection against SARS-CoV-2 transmission by a parenteral prime-Intranasal boost vaccine strategy. | EBioMedicine | 2022 | 36088218 | PubTator, text mining | PubMed |
| The SIRT1-HMGB1 axis: Therapeutic potential to ameliorate inflammatory responses and tumor occurrence. | Front Cell Dev Biol | 2022 | 36081910 | PubTator, text mining | PubMed |
| Characterization of the Newly Established Homoharringtonine- (HHT-) Resistant Cell Lines and Mechanisms of Resistance. | J Oncol | 2022 | 36081671 | PubTator, text mining | PubMed |
| Synthesis, Characterization and Anticancer Efficacy Studies of Iridium (III) Polypyridyl Complexes against Colon Cancer HCT116 Cells. | Molecules | 2022 | 36080200 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/799/papers?page=36